Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa
Cells · 2023
DOI: 10.3390/cells12222663 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Dada Oluwaseyi Temilola und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Craniofacial Biology, Faculty of Dentistry, University of the Western Cape, Tygerberg Hospital, Cape Town 7505, South Africa. Hauptthemen laut MEDLINE: Head and Neck Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of the Western Cape, South African Medical Research Council (SAMRC), Sibusiso Bengu Development Grant (SBDG).
Abstract (Originalsprache)
The rising mortality and morbidity rate of head and neck cancer (HNC) in Africa has been attributed to factors such as the poor state of health infrastructures, genetics, and late presentation resulting in the delayed diagnosis of these tumors. If well harnessed, emerging molecular and omics diagnostic technologies such as liquid biopsy can potentially play a major role in optimizing the management of HNC in Africa. However, to successfully apply liquid biopsy technology in the management of HNC in Africa, factors such as genetic, socioeconomic, environmental, and cultural acceptability of the technology must be given due consideration. This review outlines the role of circulating molecules such as tumor cells, tumor DNA, tumor RNA, proteins, and exosomes, in liquid biopsy technology for the management of HNC with a focus on studies conducted in Africa. The present state and the potential opportunities for the future use of liquid biopsy technology in the effective management of HNC in resource-limited settings such as Africa is further discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Craniofacial Biology, Faculty of Dentistry, University of the Western Cape, Tygerberg Hospital, Cape Town 7505, South Africa.
- Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, University of the Western Cape, Tygerberg Hospital, Cape Town 7505, South Africa.
- Division of Dermatology, Department of Medicine, Faculty of Health Sciences and Groote Schuur Hospital, University of Cape Town, Cape Town 7925, South Africa.
- Division of Otorhinolaryngology, Department of Surgical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Hospital, Cape Town 7505, South Africa.
ORCID-Profile: Dada Oluwaseyi Temilola, Henry Ademola Adeola, Manogari Chetty
Förderung
- University of the Western Cape
- South African Medical Research Council (SAMRC)
- Sibusiso Bengu Development Grant (SBDG)
Zitieren
APA
Temilola, D. O., Adeola, H. A., Grobbelaar, J., & Chetty, M. (2023). Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa. Cells. https://doi.org/10.3390/cells12222663
Vancouver
Temilola DO, Adeola HA, Grobbelaar J, Chetty M. Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa. Cells. 2023. doi:10.3390/cells12222663
BibTeX
@article{Temilola2023,
author = {Temilola, Dada Oluwaseyi and Adeola, Henry Ademola and Grobbelaar, Johan and Chetty, Manogari},
title = {Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12222663}
}
EUVIMED